A) Only synaptic excitation B) The release of calcium ions C) The balance of synaptic excitation and inhibition D) Only synaptic inhibition
A) By enhancing inhibition or reducing excitation B) By increasing excitation only C) By completely blocking all neuronal signals D) By destroying motor neurons
A) By mimicking or enhancing endogenous inhibitory substances like GABA B) By blocking acetylcholine receptors C) By depleting GABA levels in the brain D) By increasing dopamine production
A) Exclusively in peripheral nerves B) Only in cardiac muscle tissue C) Only at the neuromuscular junction D) Cortex, brain stem, or spinal cord
A) Because they do not affect the nervous system at all B) Because they only act on the spinal cord C) Not every agent in this class has CNS activity, such as dantrolene D) Because they all act exclusively on peripheral muscles
A) As a purely peripheral agent B) As a centrally acting muscle relaxant C) As a non-steroidal anti-inflammatory drug D) As an antidepressant
A) As a directly acting agent B) As an anticonvulsant C) As a centrally acting agent D) As a narcotic
A) Anesthetic B) Analgesic C) Spasmolytic D) Antipyretic
A) Ibuprofen B) Carisoprodol C) Paracetamol D) Aspirin
A) Baclofen B) Cyclobenzaprine C) Diazepam D) Dantrolene
A) Hypertension B) Asthma C) Type 2 diabetes D) Fibromyalgia
A) Yes B) Only in severe cases C) No D) Only for elderly patients
A) Opioids or steroids B) Paracetamol or NSAIDs C) Antidepressants or anticonvulsants D) Antibiotics or antivirals
A) NSAIDs B) Barbiturates C) Opioids D) Antidepressants
A) Immunity to chronic pain B) Reduction in blood pressure C) Complete cure for fibromyalgia D) Benefit to treatment with NSAIDs
A) Robust high-quality evidence B) Extensive double-blind evidence C) No high-quality evidence D) Definitive clinical trial evidence
A) Yes, cyclobenzaprine is the most effective B) No drug has been shown to be better than another C) Yes, carisoprodol is superior to all others D) Yes, dantrolene is the least effective
A) Insomnia and anxiety B) Dizziness and drowsiness C) Hypertension and tachycardia D) Weight gain and hair loss
A) High risk of causing kidney failure B) Extreme financial cost of manufacturing C) Possible abuse and interaction with other drugs D) Interference with digestive enzymes
A) Speed of physical elimination B) Adverse-effect profile, tolerability, and cost C) Brand name popularity and color D) Recommendation by the World Health Organization
A) Cardiovascular conditions B) Neurological conditions such as spasticity C) Gastrointestinal conditions D) Orthopedic conditions
A) Cerebral palsy and multiple sclerosis B) ALS and muscular dystrophy C) Parkinson's disease and Alzheimer's disease D) Epilepsy and Huntington's disease
A) CNS effects B) Renal effects C) Cardiovascular effects D) Gastrointestinal effects
A) The peripheral nervous system B) Skeletal muscle tissue C) The neuromuscular junction D) The CNS
A) Lactic acid accumulation causes spasms B) Nerve compression directly triggers pain C) Pain induces spasm and spasm causes pain D) Muscle fibers tear during stress
A) Considerable evidence contradicts this theory B) Medical consensus fully accepts this theory C) FDA studies have verified this theory D) Strong evidence proves this theory
A) Cardiologists B) Rheumatologists C) Orthopedic surgeons D) Neurologists
A) To prevent morning stiffness B) To block pain receptors C) To increase stage 4 sleep D) To lower blood pressure
A) Patients heal broken bones faster B) Patients build muscle mass overnight C) Patients feel more refreshed in the morning D) Patients experience immediate weight loss
A) Dantrolene B) Tizanidine C) Baclofen D) Metaxalone
A) Metaxalone and methocarbamol B) Baclofen and dantrolene C) Diazepam and carisoprodol D) Cyclobenzaprine and tizanidine
A) Those with a history of high blood pressure B) Those with seasonal allergies C) Those with lactose intolerance D) Those with a history of drug or alcohol addiction
A) Serotonin B) Dopamine C) Acetylcholine D) GABA
A) Polarization B) Inhibition C) Metabolism D) Excitation
A) 2000 B) 1950 C) 1973 D) 1985
A) Hypertension B) Fibromyalgia C) Tension headaches D) Low back pain
A) Anticoagulants B) Spasmolytics C) Diuretics D) Beta-blockers
A) Temporary paralysis. B) Increased muscle tone and strength. C) Permanent muscle relaxation. D) Enhanced neurological reflexes.
A) Curare. B) Hemlock. C) Belladonna. D) Strychnine.
A) Tubocurarine. B) Atropine. C) Cocaine. D) Morphine.
A) Acetylcholine. B) Dopamine. C) Serotonin. D) Adrenaline.
A) 1959. B) 1943. C) 1962. D) 1977.
A) 1959. B) 1962. C) 1977. D) 1943.
A) August 1977. B) August 1943. C) August 1959. D) August 1962.
A) August 1959. B) August 1962. C) August 1985. D) August 1977.
A) Opioid. B) Barbiturate. C) Anticholinergic. D) Benzodiazepine.
A) Diazepam. B) Baclofen. C) Clonidine. D) Atropine.
A) Chlorzoxazone. B) Dantrolene. C) Tetrazepam. D) Metaxalone.
A) Ibuprofen. B) Penicillin. C) Aspirin. D) Methocarbamol.
A) Mephenoxalone. B) Paracetamol. C) Lisinopril. D) Omeprazole.
A) Metaxalone. B) Meprobamate. C) Cyclobenzaprine. D) Tizanidine.
A) Anticholinergics. B) Methaqualone. C) Clonidine relatives. D) Benzodiazepines.
A) Only when combined with antibiotics. B) No. C) Only in veterinary medicine. D) Yes.
A) Baclofen. B) Equagesic. C) Metaxalone. D) Dantrolene.
A) Fentanyl preparations. B) Morphine patches. C) Codeine syrups. D) Tramadol tablets.
A) Homeopathic opium dilutions. B) Synthetic opium isolates. C) Whole opium products. D) Topical opium creams.
A) Ketobemidone. B) Methadone. C) Oxycodone. D) Hydrocodone.
A) Sodium ions B) Potassium ions C) Calcium ions D) Chloride ions
A) Three B) Four C) One D) Two
A) Mg2+ B) Na+ C) Ca2+ D) K+
A) A calcium ion bond B) A flexible sodium channel C) An acetylcholine esterase bridge D) A rigid carbon ring system
A) Central nervous system B) Skin epithelium C) Muscle membrane D) Motor end plate
A) Reverse polarization B) Endocytosis C) Active transport D) Diffusion
A) Antagonist B) Agonist C) Inhibitor D) Enzyme
A) Bone mineralization B) Kidney failure C) Dependence D) Permanent blindness
A) Alpha-2 adrenergic receptors B) Ryanodine receptors C) GABAA receptors D) GABAB receptors
A) Increased potassium ion conductance B) Decreased potassium ion conductance C) Decreased chloride ion transport D) Increased sodium ion influx
A) It depresses excitatory feedback from muscles B) It increases excitatory feedback from muscles C) It enhances calcium release from the sarcoplasmic reticulum D) It stops all electrical activity in the muscle fiber
A) Extracellular fluid B) Cell nucleus C) Mitochondria D) Sarcoplasmic reticulum
A) Alpha-2 adrenergic receptor channel B) Ryanodine receptor channel C) Glycine receptor channel D) GABAA receptor channel
A) They are unaffected B) They are stimulated to contract faster C) They are completely paralyzed D) They are depressed only slightly
A) Insomnia B) Sedation C) Muscle spasms D) Hyperactivity
A) Weight gain B) Dry mouth C) Increased appetite D) Hair loss
A) High energy B) Rapid weight loss C) Blurred vision D) Improved hearing
A) Muscle growth B) Insomnia C) Extreme hunger D) Hallucinations
A) Temporary fatigue B) Slight dry mouth C) Mild drowsiness D) Severe allergic reactions |